Compare SXT & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXT | TFX |
|---|---|---|
| Founded | 1882 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.8B |
| IPO Year | 1994 | 1994 |
| Metric | SXT | TFX |
|---|---|---|
| Price | $113.48 | $127.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | $121.00 | ★ $138.75 |
| AVG Volume (30 Days) | 373.4K | ★ 536.3K |
| Earning Date | 04-24-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.36% | 1.02% |
| EPS Growth | ★ 7.48 | N/A |
| EPS | ★ 1.04 | N/A |
| Revenue | $1,396,499,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | $8.99 | $15.97 |
| Revenue Next Year | $9.45 | $5.15 |
| P/E Ratio | $107.88 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $82.60 | $100.18 |
| 52 Week High | $129.35 | $139.67 |
| Indicator | SXT | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 47.76 | 46.17 |
| Support Level | $110.17 | $124.49 |
| Resistance Level | $118.67 | $135.21 |
| Average True Range (ATR) | 3.57 | 3.76 |
| MACD | -0.75 | -0.70 |
| Stochastic Oscillator | 21.38 | 23.49 |
Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are: Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.